摘要: |
[目的]观察口服嘎日迪散治疗慢性溃疡性结肠炎的疗效。[方法]将120例溃疡性结肠炎患者按随机数字表法分为治疗组60例,采用口服嘎日迪散治疗;对照60例,采用口服柳氮磺嘧啶(SASP)治疗。[结果]治疗组总有效率为93.3%,对照组总有率为73.3%,两组比较具有统计学差异(P<0.05);两组治疗前后腹痛、腹泻、黏液脓血便、里急后重主要临床症状同组比较差异有统计学意义(P<0.05)。[结论]嘎日迪散治疗溃疡性结肠炎疗效显著,且无不良反应。 |
关键词: 溃疡性结肠炎 蒙医药疗法 嘎日迪散 |
DOI:10.11656/j.issn.1672-1519.2012.01.06 |
分类号: |
基金项目:中国少数民族传统医学教育部创新团队资助项目(IRT0871) |
|
Clinical observation on Garidisan in 60 patients with ulcerative colitis |
CUI Jian1, PANG Zong-ran1, DE Li-ge-ma2, LU Bi-nan1, LIU Wei-zhi1
|
1.China Minority Traditional Medical Center, Minzu University of China, Beijing 100081, China;2.Inner Mongolia Medical College, Huhehaote 010059, China
|
Abstract: |
[Objective] To observe the clinical effect of Garidisan in treating ulcerative colitis.[Methods] One hundred and twenty patients were randomly divided into two groups.Sixty patients in treatment group were treated with Garidisan,while 60 patients in control group received oral Salazosulfadimidine(SASP).[Results] The effective rate of treatment group was 93.3% and control group was 73.3%.There were significant differences between two groups(P<0.05).After treatment of Garidisan,the main symptoms of ulcerative colitis,such as diarrhea,abdominal pain,mucous stool with pus and blood and tenesmus,were significantly improved.[Conclusion] Garidisan has a significant clinical effect in treating ulcerative colitis and its signs without any adverse reaction. |
Key words: ulcerative colitis Mongolian medicine therapy Garidisan |